Allstate (ALL) to Release Quarterly Earnings on Wednesday

Allstate (NYSE:ALL) is expected to announce its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect the company to announce earnings of $8.72 per share and revenue of $17.2335 billion for the quarter. Investors may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, February 5, 2026 at 9:00 AM ET.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, November 5th. The insurance provider reported $11.17 EPS for the quarter, topping analysts’ consensus estimates of $5.48 by $5.69. The company had revenue of $17.26 billion during the quarter, compared to analysts’ expectations of $16.59 billion. Allstate had a net margin of 12.53% and a return on equity of 35.42%. Allstate’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period last year, the business earned $3.91 EPS. On average, analysts expect Allstate to post $19 EPS for the current fiscal year and $22 EPS for the next fiscal year.

Allstate Stock Down 0.7%

NYSE:ALL opened at $194.73 on Wednesday. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.32. Allstate has a twelve month low of $176.00 and a twelve month high of $215.89. The company has a market cap of $50.96 billion, a PE ratio of 6.30, a P/E/G ratio of 0.43 and a beta of 0.24. The company’s 50 day moving average is $205.40 and its two-hundred day moving average is $203.40.

Allstate Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 2nd. Stockholders of record on Monday, December 1st were issued a dividend of $1.00 per share. The ex-dividend date of this dividend was Monday, December 1st. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.1%. Allstate’s payout ratio is 12.95%.

Analyst Upgrades and Downgrades

ALL has been the subject of a number of research reports. Wall Street Zen cut Allstate from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 8th. Zacks Research cut Allstate from a “strong-buy” rating to a “hold” rating in a research note on Friday, December 19th. Wells Fargo & Company upped their target price on Allstate from $216.00 to $223.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 13th. Mizuho set a $255.00 price target on shares of Allstate in a research report on Wednesday, January 14th. Finally, Roth Mkm upped their price objective on shares of Allstate from $230.00 to $240.00 and gave the company a “buy” rating in a report on Wednesday, November 26th. Three research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $236.19.

Insider Buying and Selling

In other news, insider Suren Gupta sold 19,593 shares of Allstate stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average price of $210.00, for a total transaction of $4,114,530.00. Following the completion of the transaction, the insider directly owned 100,646 shares of the company’s stock, valued at $21,135,660. The trade was a 16.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In the last 90 days, insiders sold 48,400 shares of company stock valued at $10,313,256. Corporate insiders own 1.70% of the company’s stock.

Institutional Trading of Allstate

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Woodline Partners LP acquired a new position in shares of Allstate in the third quarter worth about $148,641,000. Ameriprise Financial Inc. increased its stake in shares of Allstate by 52.7% in the 2nd quarter. Ameriprise Financial Inc. now owns 1,385,901 shares of the insurance provider’s stock valued at $279,062,000 after purchasing an additional 478,598 shares in the last quarter. Boston Partners raised its holdings in Allstate by 14.9% in the 3rd quarter. Boston Partners now owns 3,050,780 shares of the insurance provider’s stock worth $654,652,000 after purchasing an additional 395,195 shares during the period. Credit Agricole S A purchased a new position in Allstate during the third quarter worth approximately $64,923,000. Finally, Amundi grew its holdings in Allstate by 22.8% in the third quarter. Amundi now owns 1,546,855 shares of the insurance provider’s stock valued at $323,030,000 after purchasing an additional 287,634 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

About Allstate

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.